分类： science

A landmark discovery of three new microbial strains extracted from sargassum is set to reshape Barbados’ scientific and economic trajectory, opening new pathways for intellectual property development, advanced research, and high-value commercial biotech manufacturing, according to the island nation’s Minister of Science and Technology Jonathan Reid.

The breakthrough discovery was made by Dr. Bidyut Mohapatra, a researcher affiliated with the University of the West Indies. Reid described the finding as a transformative step forward for Barbados’ growing innovation ecosystem, aligned with the government’s long-term goal to position the country as a leading regional center for technological and biological research. In an interview with Barbados TODAY, Reid confirmed that the government is actively moving through the legal process to secure formal intellectual property rights for the new strains.

Reid emphasized that securing local patent protection aligns with the lead researcher’s own vision for the discovery. “To Dr Mohapatra’s credit, that’s exactly what he wanted,” Reid stated. “He named the strains after Barbados, and his dream was to patent them here. We are supporting this process through coordination with the Attorney General’s office.” Beyond navigating the patent application process, the government is working to formalize Dr. Mohapatra’s role in continued research, creating opportunities for him to expand his work in partnership with local government entities, Reid added. This approach is part of a broader strategy to retain top research talent and strengthen Barbados’ domestic scientific capacity by rewarding groundbreaking work done within the country.

Infrastructure development to support this growing scientific sector is already well underway across multiple sites in Barbados. “We are making significant progress on our plan to build Barbados as a scientific hub, with ongoing projects at Newton and the development of Greenland as a fully operational scientific park,” Reid explained. “Hosting world-class scientists carrying out cutting-edge research from our island has always been a core part of our national strategy.”

Reid noted that fostering a welcoming, high-capacity environment for advanced scientific research delivers two key long-term benefits: it encourages leading international experts to base their work in Barbados, and it inspires young Barbadians to pursue careers in STEM fields. “When researchers choose to come here on their own volition, do incredible work, and invest deeply in our country’s development, we want to partner with them to celebrate and support their efforts,” he said. “This discovery also serves as inspiration for young Barbadians interested in any scientific field, from oceanography to geology, and the rise of AI opens even more potential for groundbreaking research to be conducted right here from our island.”

While Reid acknowledged that international patent applications are time-intensive, multi-step legal processes, he reassured the public that all components of the application are moving forward as planned. Beyond intellectual property, the discovery is prompting a national reevaluation of how Barbados leverages its vast marine resources. Though Barbados’ landmass is only 166 square miles, the country controls a 45,000-square-mile Exclusive Economic Zone (EEZ) that holds a wealth of underutilized resources, including marine microbes, minerals, and other natural assets that have not yet been developed for economic gain.

The government’s current priority is to build a cohesive legal, financial, and industrial framework that can translate novel scientific discoveries like these microbial strains into marketable high-value commercial products. Reid said the discovery will act as a blueprint for rethinking the relationship between scientific research and industrial development in Barbados. “Part of this process is building domestic manufacturing capacity right here in Barbados,” he noted. “We need to become a space where we generate new, important knowledge, and convert that knowledge directly into sustainable commercial activity.”

To support the growth of advanced manufacturing in the biotech sector, Barbados is expanding international partnerships and courting additional life sciences companies to establish a presence on the island. Through a strategic alliance with the United Nations Industrial Development Organisation (UNIDO), the country is working to establish itself as a model advanced manufacturing hub for small island developing states. Reid announced that the public can expect major updates in the coming months regarding the integration of laboratory technologies and robotics into domestic production processes. Ultimately, Barbados aims to turn its naturally occurring marine resources – including the newly discovered sargassum-derived microbes – into high-value commercial products for global markets, demonstrating that what is often seen as a marine challenge can be transformed into the foundation of a thriving new domestic industry.

A groundbreaking scientific discovery made by a local researcher at the University of the West Indies Cave Hill campus has positioned Barbados to claim potentially multi-billion-dollar opportunities in global life sciences, after the island nation moved to secure full intellectual property rights to the find, according to the top official of Barbados’ export promotion agency. The discovery, a collection of unique microbial strains, was made by Dr. Bidyut Mohapatra, a scientist based at the institution. The push for national patent protection began after Dr. Mohapatra presented his preliminary findings at a major scientific conference hosted in the United States, where three of the world’s largest pharmaceutical companies immediately approached him with private offers to purchase the rights to his work outright. Rejecting sizable private payouts that would have moved the discovery outside of Barbados’ control, the researcher opted instead to partner with the Barbadian government to pursue international patent protection under national ownership.

Mark Hill, Chief Executive Officer of Export Barbados, hailed both Dr. Mohapatra’s commitment to keeping the discovery anchored in his host country and the government’s rapid response to advance the patent process, framing the development as a transformative opportunity for Barbados’ industrial future. “Securing full intellectual property rights within Barbados’ jurisdiction is the most critical foundational step we can take at this stage,” Hill noted. “Dr. Mohapatra has taken exactly the right approach, and both the researcher and the government have shown deep commitment to locking in these rights, then leveraging them as a core pillar of our ongoing national industrialization strategy.”

The initiative to advance the patent application is being led by Jonathan Reid, Barbados’ Minister of Industry, Innovation, Science and Technology, following closed-door discussions between Reid, Prime Minister Mia Mottley, and Dr. Mohapatra himself. Hill explained that the project aligns perfectly with Export Barbados’ long-term strategic framework, which focuses on building high-value domestic industries around what the agency calls the “3Ms”: molecules, microbes, and materials. The strategy centers on converting underutilized local biological resources – ranging from native seaweed to naturally occurring marine and soil microbes – into high-value pharmaceutical products, nutritional supplements, and sustainable biotechnological solutions.

“Barbados has always been a science-driven nation, historically,” Hill emphasized. “We were once global leaders in fermentation science, and the work Dr. Mohapatra is advancing puts us back on that map as a hub for cutting-edge biological research. This is a core part of our broader vision to re-industrialize the island around knowledge-based science and technology sectors.” To support Dr. Mohapatra through the complex international patent process, Export Barbados is deploying its specialized “ID to IP” program, which provides local researchers with the full range of legal, administrative, and structural support needed to secure global patent protection. The program’s core priority in this case is to solidify Barbados’ full ownership of the discovery before any negotiations with global pharmaceutical firms begin.

Hill stressed that securing intellectual property rights upfront is non-negotiable for the nation’s long-term benefit. “The first step must always be to lock in the patent and protect Barbados’ ownership,” he explained. “Only after the patent is fully secured do we move forward to negotiate licensing agreements with interested pharmaceutical partners. If we had handed these microbes over to large global companies without securing our IP first, we would have effectively given away our most valuable asset and destroyed any leverage we have in future negotiations.” Solid legal ownership gives Barbados far stronger negotiating power, particularly because these microbial strains show promising potential to address three of the world’s most pressing and high-value global challenges: antimicrobial drug resistance, microplastic pollution, and ongoing degradation of ocean ecosystems.

While Hill cautioned that it is too early in the process to attach a precise monetary value to the discovery, he made clear that the opportunity scales well into billions of dollars rather than millions. “Antimicrobial resistance alone is a massive, growing crisis for the global healthcare system, and solving even a portion of that problem represents a billion-dollar market on its own,” he noted. “When you add in the capacity of these microbes to break down microplastics and reverse ocean damage, this is not a million-dollar opportunity – this is a multi-billion-dollar prospect for Barbados.”

Beyond immediate financial gains from commercial partnerships, Hill argued that ongoing royalties, licensing fees, and reinvestment into local research could revitalize Barbados’ entire scientific community, building on the island nation’s long history of excellence in life sciences that stretches back to the late 19th century. Barbados first built its global scientific reputation through pioneering work in sugarcane genetics, agricultural innovation, and rum fermentation, and a return to cutting-edge biological research is viewed as a natural extension of the island’s existing strengths.

“Barbados has deep historical roots in the life sciences industrial sector,” Hill said. “This development puts us back at the forefront of the field we have long excelled in. It proves that even as a small island nation, we can produce world-leading scientific capability. The value that comes from this level of innovative research can only set us up for an exciting future across the whole range of life science industries that will grow from this discovery.”

This modern scientific breakthrough echoes a pivotal moment in Barbados’ 19th-century economic and scientific history. When the global sugar industry faced collapse in the 1880s – squeezed by competition from European sugar beet producers, widespread drought across the West Indies, and devastating plant disease – Barbadian agronomist John Redman Bovell funded independent experimental breeding programs for new sugarcane varieties out of his own pocket. Abandoning the widely grown but vulnerable Bourbon cane variety, Bovell focused his work on the hardy, high-yield White Transparent strain. His selective breeding work turned Barbados into one of the Caribbean’s leading sugarcane breeding hubs, saving the island’s core industry at the time. Beyond sugarcane, Bovell also developed multiple high-performing strains of Sea Island cotton, another critical cash crop for the island. Much of his pioneering research was launched at the Groves site in St. George, and research work at that location continues to this day. Decades after his death, Bovell’s contributions were honored when his portrait was featured on Barbados’ $2 banknote when it was first introduced in 1980.

Against a backdrop of growing small island nations’ push to retain control over their unique natural resources and scientific breakthroughs, Barbados is moving forward to secure international patent rights for three newly identified microorganisms extracted from invasive sargassum seaweed, following expressions of acquisition interest from major global pharmaceutical firms. Led by the discovery team at The University of the West Indies (UWI) Cave Hill campus, the Mia Mottley-led administration has rejected outright sales offers from multinational corporations to lock in long-term commercial, environmental and financial benefits for the Caribbean nation.

The groundbreaking discovery was made by Professor Bidyut Mohapatra, head of research in UWI’s Department of Biological and Chemical Sciences, who first shared the findings at a Washington DC conference hosted by the American Society for Microbiology. Shortly after his presentation, three separate industry entities – including one large multinational pharmaceutical giant – reached out to Mohapatra with offers to purchase the novel microbes outright to develop commercial applications.

Rather than accept an immediate, short-term payout that would cede all long-term gains to foreign firms, Mohapatra and the Barbadian government have opted to pursue patent protection. In an exclusive interview with Barbados TODAY, Mohapatra explained the strategic logic behind the decision: selling the intellectual property today would net only a few thousand dollars in immediate revenue, while the acquiring corporation would go on to earn millions in profits from downstream development. By contrast, securing a patent costs less than US$50,000 and positions the government to earn close to US$1 million in long-term returns, while retaining full control over partnership and licensing terms.

Of the three new microbial species identified in local sargassum populations, two have been named to honor Barbados’ contribution to the research: Chrysobacterium barbadense and Arthrobacter bajanensis. The third, Streptomyces sargassi, carries extraordinary pharmaceutical potential that has caught the attention of global drug developers. As Mohapatra notes, the Streptomyces genus is the source of roughly 70% of all antibiotics currently in clinical use, and the odds of discovering a novel biologically active strain are as low as 0.001%. Remarkably, this newly identified strain produces 19 entirely new antibiotic and antiviral compounds, opening unprecedented pathways for new drug development to address growing global antimicrobial resistance.

Beyond pharmaceutical applications, the newly discovered microbes carry meaningful potential for environmental and industrial innovation. Arthrobacter bajanensis shows unique promise as a bioremediation tool for cleaning up marine oil spills, offering a natural, low-cost alternative to traditional chemical cleanup methods. Chrysobacterium barbadense produces specialized enzymes that can support biofuel production, methane capture, and natural nitrogen fixation – aligning directly with Barbados’ global leadership on climate action.

Prime Minister Mia Mottley, who has emerged as one of the world’s most prominent advocates for a binding global methane reduction treaty modeled on the 1987 Montreal Protocol, has personally backed the patent initiative. Mottley has long argued that voluntary industry pledges are insufficient to cut methane emissions, noting that methane is far more heat-trapping than carbon dioxide but has a far shorter atmospheric lifespan; rapid cuts today would buy the world critical time to transition to net-zero carbon economies.

To advance the research and development of the microbes ahead of patent approval, which typically takes three to five years for a United States patent, Mottley has granted Mohapatra’s team full access to Barbados’ cutting-edge Living Lab initiative. The facility is being developed as a regional scientific hub, designed to engage local students and inspire the next generation of Barbadian scientists, rather than exporting the breakthrough technology overseas. Mohapatra’s ultimate goal is to support local Barbadian companies to spin off new industries built around the microbial discoveries, keeping the intellectual property anchored to the nation where it was discovered.

The naming of two species for Barbados has already elevated the country’s international scientific profile, drawing requests for research collaboration from regional neighbors including the U.S. Virgin Islands and Martinique, as well as leading global scientific organizations. For Mohapatra, the milestone carries personal as well as national pride: “The first time a microorganism has been named in honour of Barbados, I felt proud to contribute. We now have two microbes present carrying the country’s name in the microbial world. Once the patent process is finalised, the intellectual property remains ours, ensuring the discovery that originated from our land continues to benefit our people.”